OBJECTIVE: To investigate potential associations between cognitive function and/or impairment and age-related macular degeneration (AMD) and visual impairment in the Age-Related Eye Disease Study (AREDS). METHODS: The AREDS is an 11-center natural history study of AMD and age-related cataract. The AREDS Cognitive Function Battery was administered to 2946 participants. The battery consists of 6 neuropsychological tests measuring performance in several cognitive domains. The Dunnett multiple comparison test was used to identify differences by AMD and visual acuity severity. The relationship with cognitive impairment was also assessed using logistic regression. RESULTS: Mean scores of instruments in the AREDS Cognitive Function Battery declined with increased macular abnormalities and reduced visual acuity. After adjustment for age, sex, race, education, smoking status, diabetes mellitus, hypertension, and depression, increased macular abnormalities (trend P value <.05) reduced mean cognitive function scores as measured by the Modified Mini-Mental State Examination and the Wechsler Logical Memory Scale. Reduced vision was found to be associated with reduced mean cognitive function scores as measured by the Modified Mini-Mental State Examination and letter and verbal fluency tasks. Persons with vision worse than 20/40 OU were more likely to be cognitively impaired (Modified Mini-Mental State Examination score <80) (odds ratio, 2.88 [95% confidence interval, 1.75-4.76]) compared with persons with visual acuity of 20/40 or better OU. CONCLUSION: These data suggest a possible association of advanced AMD and visual acuity with cognitive impairment in older persons.
OBJECTIVE: To investigate potential associations between cognitive function and/or impairment and age-related macular degeneration (AMD) and visual impairment in the Age-Related Eye Disease Study (AREDS). METHODS: The AREDS is an 11-center natural history study of AMD and age-related cataract. The AREDS Cognitive Function Battery was administered to 2946 participants. The battery consists of 6 neuropsychological tests measuring performance in several cognitive domains. The Dunnett multiple comparison test was used to identify differences by AMD and visual acuity severity. The relationship with cognitive impairment was also assessed using logistic regression. RESULTS: Mean scores of instruments in the AREDS Cognitive Function Battery declined with increased macular abnormalities and reduced visual acuity. After adjustment for age, sex, race, education, smoking status, diabetes mellitus, hypertension, and depression, increased macular abnormalities (trend P value <.05) reduced mean cognitive function scores as measured by the Modified Mini-Mental State Examination and the Wechsler Logical Memory Scale. Reduced vision was found to be associated with reduced mean cognitive function scores as measured by the Modified Mini-Mental State Examination and letter and verbal fluency tasks. Persons with vision worse than 20/40 OU were more likely to be cognitively impaired (Modified Mini-Mental State Examination score <80) (odds ratio, 2.88 [95% confidence interval, 1.75-4.76]) compared with persons with visual acuity of 20/40 or better OU. CONCLUSION: These data suggest a possible association of advanced AMD and visual acuity with cognitive impairment in older persons.
Authors: Tien Yin Wong; Ronald Klein; F Javier Nieto; Suzana A D Moraes; Thomas H Mosley; David J Couper; Barbara E K Klein; Lori L Boland; Larry D Hubbard; A Richey Sharrett Journal: Am J Ophthalmol Date: 2002-12 Impact factor: 5.258
Authors: M I Geerlings; R A Schoevers; A T Beekman; C Jonker; D J Deeg; B Schmand; H J Adèr; L M Bouter; W Van Tilburg Journal: Br J Psychiatry Date: 2000-06 Impact factor: 9.319
Authors: Eva Biringer; Arnstein Mykletun; Alv A Dahl; A David Smith; Knut Engedal; Harald A Nygaard; Anders Lund Journal: Int J Geriatr Psychiatry Date: 2005-10 Impact factor: 3.485
Authors: Ha T Nguyen; Sandra A Black; Laura A Ray; David V Espino; Kyriakos S Markides Journal: J Gerontol A Biol Sci Med Sci Date: 2002-03 Impact factor: 6.053
Authors: Robert S Wilson; Carlos F Mendes De Leon; Lisa L Barnes; Julie A Schneider; Julia L Bienias; Denis A Evans; David A Bennett Journal: JAMA Date: 2002-02-13 Impact factor: 56.272
Authors: Robert S Wilson; L L Barnes; C F Mendes de Leon; N T Aggarwal; J S Schneider; J Bach; J Pilat; L A Beckett; S E Arnold; D A Evans; D A Bennett Journal: Neurology Date: 2002-08-13 Impact factor: 9.910
Authors: Heather E Whitson; Rahul Malhotra; Angelique Chan; David B Matchar; Truls Østbye Journal: Asia Pac J Public Health Date: 2012-04-24 Impact factor: 1.399
Authors: D Diane Zheng; Bonnielin K Swenor; Sharon L Christ; Sheila K West; Byron L Lam; David J Lee Journal: JAMA Ophthalmol Date: 2018-09-01 Impact factor: 7.389
Authors: Joel E Soler; Margaret Stumpfig; Yu-Ping Tang; Alfred J Robison; Antonio A Núñez; Lily Yan Journal: Neuroscience Date: 2019-01-26 Impact factor: 3.590
Authors: Mark W Albers; Grover C Gilmore; Jeffrey Kaye; Claire Murphy; Arthur Wingfield; David A Bennett; Adam L Boxer; Aron S Buchman; Karen J Cruickshanks; Davangere P Devanand; Charles J Duffy; Christine M Gall; George A Gates; Ann-Charlotte Granholm; Takao Hensch; Roee Holtzer; Bradley T Hyman; Frank R Lin; Ann C McKee; John C Morris; Ronald C Petersen; Lisa C Silbert; Robert G Struble; John Q Trojanowski; Joe Verghese; Donald A Wilson; Shunbin Xu; Li I Zhang Journal: Alzheimers Dement Date: 2014-07-09 Impact factor: 21.566
Authors: Heather E Whitson; Ying-Hui Chou; Guy G Potter; Michele T Diaz; Nan-Kuei Chen; Eleonora M Lad; Micah A Johnson; Scott W Cousins; Jie Zhuang; David J Madden Journal: Brain Connect Date: 2014-12-02
Authors: S Gillette Guyonnet; G Abellan Van Kan; S Andrieu; J P Aquino; C Arbus; J P Becq; C Berr; S Bismuth; B Chamontin; T Dantoine; J F Dartigues; B Dubois; B Fraysse; T Hergueta; H Hanaire; C Jeandel; S Lagleyre; F Lala; F Nourhashemi; P J Ousset; F Portet; P Ritz; P Robert; Y Rolland; C Sanz; M Soto; J Touchon; B Vellas Journal: J Nutr Health Aging Date: 2008-10 Impact factor: 4.075
Authors: Heather E Whitson; Diane Whitaker; Guy Potter; Eleanor McConnell; Fay Tripp; Linda L Sanders; Kelly W Muir; Harvey J Cohen; Scott W Cousins Journal: JAMA Ophthalmol Date: 2013-07 Impact factor: 7.389